Monthly Archives: June 2020

Life Sciences Companies: Frequent Securities Suits Frequently Dismissed | The D&O Diary

As I have documented in prior posts (for example, here), publicly traded life sciences companies are frequent targets of securities class action lawsuits. But life sciences companies’ securities litigation exposure may be well-known, it is not always as appreciated that the securities suits against life sciences companies are often dismissed. Two recent rulings in securities suits against life sciences companies…

Read More